Investigating the function of BTN3A1 and its expression in tumor tissues has provided new targets for tumor immunotherapy, allowing researchers to explore novel immune therapeutic strategies to enhance the immune response against tumors [115]. This evidence concerns the gene BTN3A1 and neoplasm.